基本信息
浏览量:37
职业迁徙
个人简介
Dr. Olson’s research centers around improving the efficacy and safety of immunotherapy. This includes a research focus on investigator-sponsored trials targeting mechanisms of resistance to PD-1 antibody therapy. He also has a research interest in improving the management of immune-related adverse events (irAE) through translational work characterizing irAE mechanisms. Dr. Olson will work both in the melanoma and developmental therapeutics (DT) programs. Within the DT program, he will focus on trials targeting mechanisms of immunotherapy resistance, and to help expand the use of cell therapy approaches in solid tumors.
研究兴趣
论文共 129 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ecaterina E. Dumbrava,Daniel Olson,Samuel Saibil,Davendra P. Sohal,Syma Iqbal, Alejandro Urgelles,Maria Apostolopoulou, Amy Mueller,Kara Moss,Deyaa Adib, Ben Schlecter
CANCER RESEARCHno. 7 (2024)
Ecaterina E. Dumbrava,Daniel Olson,Samuel Saibil,Davendra P. Sohal,Syma Iqbal, Alejandro Urgelles,Maria Apostolopoulou, Amy Mueller,Kara Moss,Deyaa Adib, Ben Schlecter
Cancer Researchno. 7_Supplement (2024)
Cancersno. 6 (2024)
Manish R. Patel,David J. Park, Stefano Tarantolo,Afshin Dowlati,Daniel Olson, Yuichiro Kaneko, Mei Tang,Serguei Soukharev, Masaomi Takizawa,Yohei Okada, Christine Fredericks, Teresa Flegel,
Cancer Researchno. 8_Supplement (2023)
Journal of clinical oncology : official journal of the American Society of Clinical Oncologyno. 18 (2023): 3397-+
Daniel J. Olson, Brian Gastman, Alicia Rowell,Madan Jagasia, Parameswaran Hari, Wen Shi, Kendall Stevinson,Katy K. Tsai
Journal of The National Comprehensive Cancer Networkno. 3.5 (2023): HSR23-110
Manish R. Patel,David J. Park, Stefano Tarantolo,Afshin Dowlati,Daniel Olson,Yuichiro Kaneko, Mei Tang,Serguei Soukharev,Masaomi Takizawa,Yohei Okada, Christine Fredericks,Teresa Flegel,
CANCER RESEARCHno. 8 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn